3.25.1 html 120 224 1 false 46 0 false 6 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.lexpharma.com/role/CoverPage Cover Page Cover 1 false false R2.htm 9952151 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.lexpharma.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.lexpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.lexpharma.com/role/CondensedConsolidatedStatementsofComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Parenthetical) Sheet http://www.lexpharma.com/role/CondensedConsolidatedStatementsofComprehensiveLossParenthetical Condensed Consolidated Statements of Comprehensive Loss (Parenthetical) Statements 5 false false R6.htm 9952155 - Statement - Condensed Consolidated Statements of Stockholders??? Equity Sheet http://www.lexpharma.com/role/CondensedConsolidatedStatementsofStockholdersEquity Condensed Consolidated Statements of Stockholders??? Equity Statements 6 false false R7.htm 9952156 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.lexpharma.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 9952157 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.lexpharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 9952158 - Disclosure - Cash and Cash Equivalents and Investments Sheet http://www.lexpharma.com/role/CashandCashEquivalentsandInvestments Cash and Cash Equivalents and Investments Notes 9 false false R10.htm 9952159 - Disclosure - Fair Value Measurements Sheet http://www.lexpharma.com/role/FairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 9952160 - Disclosure - Supplemental Financial Information Sheet http://www.lexpharma.com/role/SupplementalFinancialInformation Supplemental Financial Information Notes 11 false false R12.htm 9952161 - Disclosure - Collaboration and Strategic Alliances Sheet http://www.lexpharma.com/role/CollaborationandStrategicAlliances Collaboration and Strategic Alliances Notes 12 false false R13.htm 9952162 - Disclosure - Debt Obligations Sheet http://www.lexpharma.com/role/DebtObligations Debt Obligations Notes 13 false false R14.htm 9952163 - Disclosure - Commitments and Contingencies Sheet http://www.lexpharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 14 false false R15.htm 9952164 - Disclosure - Equity Incentive Awards Sheet http://www.lexpharma.com/role/EquityIncentiveAwards Equity Incentive Awards Notes 15 false false R16.htm 9952165 - Disclosure - Other Capital Agreements Sheet http://www.lexpharma.com/role/OtherCapitalAgreements Other Capital Agreements Notes 16 false false R17.htm 9952166 - Disclosure - Segment Information Sheet http://www.lexpharma.com/role/SegmentInformation Segment Information Notes 17 false false R18.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 18 false false R19.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 19 false false R20.htm 9955511 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.lexpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.lexpharma.com/role/SummaryofSignificantAccountingPolicies 20 false false R21.htm 9955512 - Disclosure - Cash and Cash Equivalents and Investments (Tables) Sheet http://www.lexpharma.com/role/CashandCashEquivalentsandInvestmentsTables Cash and Cash Equivalents and Investments (Tables) Tables http://www.lexpharma.com/role/CashandCashEquivalentsandInvestments 21 false false R22.htm 9955513 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.lexpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.lexpharma.com/role/FairValueMeasurements 22 false false R23.htm 9955514 - Disclosure - Supplemental Financial Information (Tables) Sheet http://www.lexpharma.com/role/SupplementalFinancialInformationTables Supplemental Financial Information (Tables) Tables http://www.lexpharma.com/role/SupplementalFinancialInformation 23 false false R24.htm 9955515 - Disclosure - Commitment and Contingencies (Tables) Sheet http://www.lexpharma.com/role/CommitmentandContingenciesTables Commitment and Contingencies (Tables) Tables 24 false false R25.htm 9955516 - Disclosure - Equity Incentive Awards (Tables) Sheet http://www.lexpharma.com/role/EquityIncentiveAwardsTables Equity Incentive Awards (Tables) Tables http://www.lexpharma.com/role/EquityIncentiveAwards 25 false false R26.htm 9955517 - Disclosure - Segment Information (Tables) Sheet http://www.lexpharma.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.lexpharma.com/role/SegmentInformation 26 false false R27.htm 9955518 - Disclosure - Cash and Cash Equivalents and Investments - Schedule of Cash and Cash Equivalents and Investments (Details) Sheet http://www.lexpharma.com/role/CashandCashEquivalentsandInvestmentsScheduleofCashandCashEquivalentsandInvestmentsDetails Cash and Cash Equivalents and Investments - Schedule of Cash and Cash Equivalents and Investments (Details) Details 27 false false R28.htm 9955519 - Disclosure - Cash and Cash Equivalents and Investments - Narrative (Details) Sheet http://www.lexpharma.com/role/CashandCashEquivalentsandInvestmentsNarrativeDetails Cash and Cash Equivalents and Investments - Narrative (Details) Details 28 false false R29.htm 9955520 - Disclosure - Fair Value Measurements (Details) Sheet http://www.lexpharma.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.lexpharma.com/role/FairValueMeasurementsTables 29 false false R30.htm 9955521 - Disclosure - Supplemental Financial Information (Details) Sheet http://www.lexpharma.com/role/SupplementalFinancialInformationDetails Supplemental Financial Information (Details) Details http://www.lexpharma.com/role/SupplementalFinancialInformationTables 30 false false R31.htm 9955522 - Disclosure - Supplemental Financial Information - Narrative (Details) Sheet http://www.lexpharma.com/role/SupplementalFinancialInformationNarrativeDetails Supplemental Financial Information - Narrative (Details) Details 31 false false R32.htm 9955523 - Disclosure - Collaboration and Strategic Alliances (Details) Sheet http://www.lexpharma.com/role/CollaborationandStrategicAlliancesDetails Collaboration and Strategic Alliances (Details) Details http://www.lexpharma.com/role/CollaborationandStrategicAlliances 32 false false R33.htm 9955524 - Disclosure - Debt Obligations (Details) Sheet http://www.lexpharma.com/role/DebtObligationsDetails Debt Obligations (Details) Details http://www.lexpharma.com/role/DebtObligations 33 false false R34.htm 9955525 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.lexpharma.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 34 false false R35.htm 9955526 - Disclosure - Commitments and Contingencies - Table (Details) Sheet http://www.lexpharma.com/role/CommitmentsandContingenciesTableDetails Commitments and Contingencies - Table (Details) Details 35 false false R36.htm 9955527 - Disclosure - Equity Incentive Awards - Narrative (Details) Sheet http://www.lexpharma.com/role/EquityIncentiveAwardsNarrativeDetails Equity Incentive Awards - Narrative (Details) Details 36 false false R37.htm 9955528 - Disclosure - Equity Incentive Awards - Summary of Weighted-Average Stock Options Assumptions (Details) Sheet http://www.lexpharma.com/role/EquityIncentiveAwardsSummaryofWeightedAverageStockOptionsAssumptionsDetails Equity Incentive Awards - Summary of Weighted-Average Stock Options Assumptions (Details) Details 37 false false R38.htm 9955529 - Disclosure - Equity Incentive Awards - Summary of Stock Option Activity (Details) Sheet http://www.lexpharma.com/role/EquityIncentiveAwardsSummaryofStockOptionActivityDetails Equity Incentive Awards - Summary of Stock Option Activity (Details) Details 38 false false R39.htm 9955530 - Disclosure - Equity Incentive Awards - Summary of Restricted Stock Units Activity (Details) Sheet http://www.lexpharma.com/role/EquityIncentiveAwardsSummaryofRestrictedStockUnitsActivityDetails Equity Incentive Awards - Summary of Restricted Stock Units Activity (Details) Details 39 false false R40.htm 9955531 - Disclosure - Other Capital Agreements (Details) Sheet http://www.lexpharma.com/role/OtherCapitalAgreementsDetails Other Capital Agreements (Details) Details http://www.lexpharma.com/role/OtherCapitalAgreements 40 false false R41.htm 9955532 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.lexpharma.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 41 false false R42.htm 9955533 - Disclosure - Segment Information - Table (Details) Sheet http://www.lexpharma.com/role/SegmentInformationTableDetails Segment Information - Table (Details) Details 42 false false All Reports Book All Reports lxrx-20250331.htm lxrx-20250331.xsd lxrx-20250331_cal.xml lxrx-20250331_def.xml lxrx-20250331_lab.xml lxrx-20250331_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true